Evaxion Biotech (EVAX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts EVAX Hot Sheet
Join SI Premium – FREE
Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of $0.01, $0.01 better than the analyst estimate of $0.00. Revenue for the quarter came in at $7.49 million.
For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Prologis makes unsolicited bid for SEGRO, valued at £12.6 billion
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
